Literature DB >> 9566955

Developmentally regulated expression and localization of fibroblast growth factor receptors in the human muscle.

V Sogos1, L Balaci, M G Ennas, P Dell'era, M Presta, F Gremo.   

Abstract

Fibroblast growth factors (FGFs) are believed to play a key role in tissue differentiation and maturation. Thus, the expression of the four members of the high-affinity tyrosine kinase FGF receptor family (FGFRs) and of the low-affinity heparan sulphate proteoglycan binding sites, syndecan-1 and perlecan, was studied in the human skeletal muscle during development. Northern blot analysis demonstrated a developmentally regulated expression of the mRNAs for FGFR-1, FGFR-3, FGFR-4, whereas only traces of FGFR-2 mRNA were found. Each receptor type had a different developmental pattern, suggesting an independent regulation. Signal for FGFR-3 was retained only in the adult muscle. Among the low-affinity FGF binding sites, perlecan was absent, whereas RNA transcript for syndecan-1 peaked at week 13 of gestation, after which a significant decrease was observed. Immunohistochemistry for FGFRs revealed that their localization changed with muscle maturation. At early embryonic stages, FGFR-3 and FGFR-4 had a scattered distribution in the tissue, and FGFR-1 was found on myotube and myofiber plasma membranes. At later stages, FGFR-1 positivity decreased and was found in a few areas of the muscle, FGFR-3 was concentrated in the nuclei of some, but not all, muscle fibers, and FGFR-4 maintained an association with plasma membrane. In adult tissue, weak positivity for FGFR-3 and FGFR-4 was observed in the connective tissue only. When immunocytochemistry was performed on human fetal myoblasts in culture, confocal microscope analysis revealed a nonhomogeneous cell membrane distribution of FGFRs. Taken together, the data strongly suggest that developmentally regulated expression and cell distribution of FGFRs play a role during muscle maturation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9566955     DOI: 10.1002/(SICI)1097-0177(199804)211:4<362::AID-AJA7>3.0.CO;2-F

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  6 in total

1.  Activated EGL-15 FGF receptor promotes protein degradation in muscles of Caenorhabditis elegans.

Authors:  Nathaniel J Szewczyk; Lewis A Jacobson
Journal:  EMBO J       Date:  2003-10-01       Impact factor: 11.598

2.  Knockdown of CDR1as Decreases Differentiation of Goat Skeletal Muscle Satellite Cells via Upregulating miR-27a-3p to Inhibit ANGPT1.

Authors:  Bismark Kyei; Emmanuel Odame; Li Li; Liu Yang; Siyuan Zhan; Juntao Li; Yuan Chen; Dinghui Dai; Jiaxue Cao; Jiazhong Guo; Tao Zhong; Linjie Wang; Hongping Zhang
Journal:  Genes (Basel)       Date:  2022-04-09       Impact factor: 4.141

3.  Fibroblast growth factor 23 does not directly influence skeletal muscle cell proliferation and differentiation or ex vivo muscle contractility.

Authors:  Keith G Avin; Julian A Vallejo; Neal X Chen; Kun Wang; Chad D Touchberry; Marco Brotto; Sarah L Dallas; Sharon M Moe; Michael J Wacker
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-03-20       Impact factor: 4.310

Review 4.  Genomic studies of mood disorders -- the brain as a muscle?

Authors:  Alexander B Niculescu
Journal:  Genome Biol       Date:  2005-03-24       Impact factor: 13.583

5.  Tumour formation by single fibroblast growth factor receptor 3-positive rhabdomyosarcoma-initiating cells.

Authors:  M Hirotsu; T Setoguchi; Y Matsunoshita; H Sasaki; H Nagao; H Gao; K Sugimura; S Komiya
Journal:  Br J Cancer       Date:  2009-11-03       Impact factor: 7.640

6.  FGFR1 inhibits skeletal muscle atrophy associated with hindlimb suspension.

Authors:  John Eash; Aaron Olsen; Gert Breur; Dave Gerrard; Kevin Hannon
Journal:  BMC Musculoskelet Disord       Date:  2007-04-10       Impact factor: 2.362

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.